Date Name Title Filing Type Shares Traded Price Total Held
Nov 30, 2011
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 196,430 -- --
May 19, 2006
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Bona fide gift 670 -- 62,424
Jan 06, 2012
Director, EVP, CSO & Pres, REGN Res Labs
Director, EVP, CSO & Pres, REGN Res Labs Form 4 Other acquisition or disposition -- -- 5,390
Jan 05, 2012
Director, EVP, CSO & Pres, REGN Res Labs
Director, EVP, CSO & Pres, REGN Res Labs Form 4 Open market or private sale of non-derivative or derivative security 27,713 $58.00 833,041
Dec 18, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Other acquisition or disposition -- -- 4,330
Dec 17, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,952 -- 5,952
Dec 17, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 94,048 -- 94,048
Dec 16, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 26,991 $7.41 590,085
Dec 16, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Open market or private sale of non-derivative or derivative security 26,991 $16.40 563,094
Dec 16, 2008
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 73,009 $7.41 636,103

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.